For most people, osteoarthritis arrives quietly. A knee that aches after a long walk. A hip that stiffens after sitting. Fingers that take time to loosen in the morning. These early signs are easy to attribute to ageing or tiredness, and for years, many people do exactly that.
By the time a diagnosis is confirmed on imaging, the cartilage loss and structural joint changes that define osteoarthritis have already been progressing, often for years without being properly identified or addressed. Understanding the causes of osteoarthritis is not an academic exercise.
It is the starting point of a treatment conversation that, if begun early and with the right specialist, can meaningfully slow progression, delay or avoid surgery, and restore a quality of life that the disease quietly erodes.
For international patients who cannot access specialist orthopaedic care at home, or for whom the cost of treatment in Western countries is prohibitive, India now offers the full spectrum of evidence-based osteoarthritis treatment, from structured physiotherapy and regenerative medicine through to joint replacement surgery, at costs that are 60 to 80 percent lower than the USA or UK. This guide connects the disease awareness to the treatment opportunity.
What Osteoarthritis Actually Is
Osteoarthritis is a heterogeneous whole-joint disease that can cause pain and is a leading cause of disability and premature work loss. It is not simply cartilage wearing away. The 2025 Nature Reviews Disease Primers definition describes OA as a whole-joint condition in which cartilage, subchondral bone, synovium, ligaments, and periarticular muscles are all affected by a complex interaction of inflammatory, metabolic, and mechanical processes.
Osteoarthritis is characterised by a marked rearrangement of the articular cartilage, resulting from focal erosion extending from the articular cartilage surface to the subchondral bone, chondrocyte hypertrophy and apoptosis, cartilage overgrowth outside the articular surface with formation of osteophytes, and ossification of subchondral bone. These alterations are mirrored by detrimental macroscopic changes, such as cartilage and ligament degeneration, secondary synovitis, and overall joint rearrangement, prompting relevant deformities.
This whole-joint involvement is why managing osteoarthritis effectively requires addressing multiple contributing factors simultaneously, not just the cartilage alone.
Why Joints Wear Down: The Real Triggers of Osteoarthritis
Risk factors for osteoarthritis primarily encompass human factors such as age, gender, obesity, genetics, and diet, as well as joint-level factors such as injury, misalignment, and abnormal loading, which interact with each other in a complex manner to influence the development of osteoarthritis. Understanding these causes individually helps patients and families identify which factors are present in their situation, and which may be modifiable before or alongside treatment.
Age: The Most Universal Contributing Factor
Among these factors, age, gender, and obesity are recognised as independent risk factors for osteoarthritis. Ageing reduces the capacity of chondrocytes, the cells responsible for maintaining cartilage, to repair damage at the rate it accumulates. Mitochondrial dysfunction in ageing chondrocytes, oxidative stress, and reduced production of growth factors collectively impair the cartilage's self-repair capacity, tipping the balance toward progressive degeneration.
Age is not a fixed determinant of outcome, however. Many people in their seventies have well-preserved joint cartilage, while some in their forties have significant degeneration. This reflects the fact that age amplifies the effect of other causes rather than acting independently.
Obesity and High Body Mass Index
Carrying a body mass index (BMI) of 25 or higher is one of the most significant, reversible drivers of osteoarthritis. In fact, a massive study tracking over 1.7 million people showed that individuals with obesity face more than three times the risk of developing knee osteoarthritis compared to those at a healthy weight. This happens through two entirely different destructive pathways:
-
The Mechanical Load: The physical physics are unforgiving. For every single kilogram of extra body weight you carry, your knee joint is forced to absorb an additional four to six kilograms of pressure with every step you take.
-
The Chemical Inflammation: Obesity damage isn't just about weight. Fat tissue (adipose tissue) acts like an active chemical factory, constantly leaking pro-inflammatory proteins like leptin and interleukin-1 into your bloodstream. This creates a systemic, body-wide inflammatory environment that actively dissolves cartilage from the inside out—which explains why people with obesity frequently suffer from osteoarthritis in non-weight-bearing joints, like the hands.
Joint Injury and Post-Traumatic Osteoarthritis
The predominant disease risk factors, obesity and joint injury, are well recognised and modifiable. Joint injuries including ACL tears, meniscal damage, articular fractures, and ligament disruptions significantly accelerate cartilage degeneration by altering joint mechanics, increasing contact stress on the cartilage surface, and triggering inflammatory mediator release that persists long after the acute injury has resolved. Post-traumatic osteoarthritis can develop within five to ten years of a significant knee injury even in young patients, and a notable increase in early-onset OA is being observed, driven in part by obesity and joint injuries. Occupational joint loading also contributes through a similar mechanism. Repetitive bending, squatting, kneeling, and heavy lifting over years of manual work create cumulative mechanical stress that accelerates cartilage degradation beyond what would otherwise occur with ageing alone.
Genetics and Hereditary Factors
Genetics contributes to osteoarthritis through multiple pathways: inherited variation in cartilage matrix composition, bone density and geometry, ligament laxity, and inflammatory response patterns. Heritability estimates for hip and knee osteoarthritis range from 40 to 65 percent across twin and family studies. Specific gene variants affecting collagen structure, cartilage metabolism, and inflammatory signalling are increasingly being identified through genome-wide association studies, providing mechanistic insights that are beginning to translate into targeted therapy development.
A family history of OA is one of the most consistent predictors of an individual's lifetime risk, particularly for hand and hip OA where the genetic contribution is proportionally stronger than for knee OA.
Metabolic Disorders: The Emerging Cause
Although aging has traditionally been viewed as the most important risk factor for osteoarthritis, an increasing amount of epidemiological evidence has highlighted the association between metabolic abnormalities and OA, particularly in younger individuals. Type 2 diabetes, dyslipidaemia, and metabolic syndrome are all independently associated with accelerated osteoarthritis progression.
Body composition, characterised by high fat mass and low lean mass, emerged as a critical factor influencing OA severity and physical function. This finding, from the OARSI Year in Review 2025, reframes the OA risk conversation beyond weight alone. Low muscle mass, even in individuals without frank obesity, impairs the dynamic joint stabilisation that muscles provide during movement, increasing cartilage contact stress. The combination of high fat mass and low lean mass represents the most adverse body composition profile for OA risk and progression.
Sex and Hormonal Factors
Women are more commonly affected by osteoarthritis than men overall, and the incidence in women increases sharply after the menopause, suggesting a role for oestrogen in maintaining cartilage integrity. Oestrogen receptors are expressed on chondrocytes, and the loss of oestrogen at menopause has been associated with accelerated cartilage degradation in some populations. This sex-based differential is most pronounced for knee and hand OA.
Malalignment and Joint Mechanics
Coronal plane malalignment of the knee, whether varus (bow-legged) or valgus (knock-kneed), concentrates mechanical load onto the medial or lateral compartment respectively, accelerating cartilage loss in the overloaded compartment disproportionately. Hip dysplasia similarly creates abnormal contact mechanics at the acetabular rim that predispose to early hip OA. These biomechanical causes of osteoarthritis are relevant because they respond to specific corrective interventions, including high tibial osteotomy for varus knee OA and periacetabular osteotomy for hip dysplasia, that can meaningfully slow progression if applied before joint damage becomes irreversible.
How Osteoarthritis Progresses: What Families Should Understand
Osteoarthritis is classified into four grades on the Kellgren-Lawrence scale based on imaging findings, ranging from grade 1 (minor osteophyte formation, no definite joint space narrowing) through grade 4 (large osteophytes, severe joint space narrowing, and subchondral sclerosis). This grading system is clinically useful because it directly informs which treatment options are available at each stage.
Your current osteoarthritis grade dictates your available treatment options. Delaying evaluation until the pain becomes unbearable often means missing the window for highly effective, non-surgical therapies.
-
Grades 1 & 2 (Early Stage): Responds exceptionally well to structured physiotherapy, targeted weight management, and activity modifications. Regenerative options like platelet-rich plasma (PRP) or hyaluronic acid injections are highly effective here to slow disease progression.
-
Grade 3 (Moderate Stage): This is the critical transition zone where advanced biological and regenerative interventions show the most meaningful benefit in successfully delaying the need for a major operation.
-
Grade 4 (End-Stage): Characterized by severe joint damage and near-complete cartilage loss. At this advanced structural stage, joint replacement surgery becomes the primary indicator to restore mobility.
Advanced Treatment Options for International Patients in India
Currently, management is primarily focused on alleviating the main symptoms of pain and obstructed function through lifestyle interventions such as self-management programmes, education, physical activity, exercise and weight management. For those who have persistent symptoms that are compromising quality of life and have not responded adequately to core treatments, joint replacement is an option.
Between conservative management and joint replacement, a spectrum of advanced interventions is now available in India that significantly expand what international patients can access.
Structured Physiotherapy and Weight Management Programmes
Structured physiotherapy targeting the muscles surrounding the affected joint, particularly quadriceps and hip abductor strengthening for knee and hip OA respectively, is the most consistently evidence-supported non-pharmacological treatment for osteoarthritis at every grade. Exercise reduces pain, improves function, and slows structural progression by reducing the contact forces transmitted through damaged cartilage during daily movement.
A greater understanding of the complex mechanisms, including inflammatory, metabolic and post-traumatic processes, that can lead to disease and of the pathophysiology of pain is helping to delineate mechanistic targets. Weight management, combined with physiotherapy, addresses the metabolic and mechanical causes of OA simultaneously and is now recognised as the most effective modifiable intervention for OA progression.
PRP Injections
Platelet-Rich Plasma (PRP) therapy processes the patient's own blood to concentrate platelets and their associated growth factors, then injects this concentrate into the affected joint. The growth factors, including transforming growth factor-beta and platelet-derived growth factor, reduce synovial inflammation and stimulate what cartilage repair capacity remains in the affected joint.
Multiple meta-analyses covering more than 40 randomised controlled trials support PRP as at least as effective as hyaluronic acid or corticosteroid for knee osteoarthritis, with benefits for pain and function lasting up to 12 months per treatment cycle. PRP is most appropriate for grade 1 to grade 3 OA, where meaningful cartilage is still present, and is used at India's leading orthopaedic hospitals as part of a comprehensive biological management programme.
Stem Cell Therapy and Orthobiologics
Mesenchymal stem cell (MSC) therapy is offered at top JCI-accredited Indian hospitals as an advanced regenerative option, primarily for patients with grade 2 or 3 osteoarthritis who want to delay or avoid joint replacement. Highly trained Indian orthopedic specialists often combine autologous cells—harvested directly from the patient's own bone marrow or fat tissue—with Platelet-Rich Plasma (PRP) to maximize cartilage healing. These advanced procedures are performed under precise ultrasound or fluoroscopic guidance inside cGMP-compliant laboratories, with high-volume centers reporting an impressive 70% to 85% patient satisfaction rate for early-to-mid stage pain relief.
Financially, the cost for this advanced treatment in India ranges from USD 3,000 to USD 8,000 per joint, making it roughly 60% to 80% more affordable than identical protocols in the US or Europe. However, because stem cell therapy is still classified as an investigational approach with outcomes that vary based on age and disease severity, it is critical to seek care only from accredited facilities. Choosing a qualified orthopedic team that maintains transparent outcome reporting ensures you receive a highly supervised, safe, and effective treatment protocol.
Hyaluronic Acid Viscosupplementation
Intra-articular hyaluronic acid injections supplement the natural joint fluid, improving lubrication and cushioning in early to moderate OA where cartilage is still partially intact. While therapeutic interventions including intra-articular injections such as corticosteroids and hyaluronic acid continue to show limited efficacy as standalone treatments in the most recent OA Year in Review, they remain a useful component of a multimodal management plan, particularly for patients who are not yet candidates for regenerative therapy or surgery.
High Tibial Osteotomy for Malalignment-Driven OA
For patients with medial compartment knee OA driven by varus malalignment, high tibial osteotomy (HTO) corrects the limb axis by cutting and realigning the tibia, redistributing load away from the damaged compartment and toward the less affected lateral compartment. HTO can meaningfully delay the need for total knee replacement, particularly in younger and more active patients, and is available at India's leading orthopaedic centres.
Total Knee and Hip Replacement
For patients with grade 3 to grade 4 osteoarthritis whose quality of life is significantly impaired by pain and functional limitation despite non-surgical treatment, joint replacement remains the most durable and effective intervention available. Total knee replacement and total hip replacement at India's NABH and JCI-accredited hospitals deliver success rates of over 90 percent with internationally certified implants from Zimmer Biomet, Stryker, and Johnson and Johnson.
Personalised treatment approaches that integrate metabolic, biomechanical, and psychosocial factors may be crucial for advancing OA care management. This is exactly the model applied at India's leading joint replacement centres, where pre-operative optimisation, robotic-assisted surgery for implant precision, and structured post-operative rehabilitation are integrated into a single coordinated pathway.
Knee replacement surgery in India costs between Rs. 2 lakh and Rs. 5.5 lakh (approximately USD 2,400 to USD 6,600) for a standard total knee replacement, and hip replacement ranges from Rs. 2.5 lakh to Rs. 6 lakh (USD 3,000 to USD 7,200). Both represent savings of 70 to 80 percent compared to equivalent procedures in the USA or UK, using the same implant systems and surgical techniques.
Why India Is Where International Patients Access OA Treatment
International patients are increasingly choosing India for osteoarthritis care to bypass lengthy waiting queues and access premium, multi-stage medical solutions at a fraction of Western costs.
The Full Spectrum Under One System
India's leading orthopaedic hospitals now offer the complete treatment ladder for osteoarthritis, from structured physiotherapy and weight management programmes, through PRP and stem cell orthobiologics, high tibial osteotomy, and robotic joint replacement, all within NABH and JCI-accredited systems that meet independently verified international standards. This means an international patient can access the right treatment for their disease grade in a single destination, rather than piecing together conservative care at home and surgery abroad.
Faster Access Without Lengthy Waiting Periods
International patients at India's private hospitals move from consultation to specialist assessment to treatment initiation within one to two weeks of arrival, a timeline that compares directly with waiting periods of six months to two years in many public healthcare systems across Africa, the Middle East, and South Asia. For OA patients in the middle grades, where treatment timing can influence how much functional capacity is preserved, this speed of access has direct clinical value.
Cost That Restores Possibility
For many international patients, the cost of OA treatment in Western countries places even basic interventions beyond reach. The same PRP injection that costs USD 800 to USD 1,500 in the USA costs USD 100 to USD 300 in India. The same knee replacement that costs USD 25,000 to USD 40,000 in the USA costs USD 2,400 to USD 6,600 in India. This gap does not reflect a difference in quality. It reflects a difference in healthcare economics that makes comprehensive, multi-stage OA treatment genuinely accessible to international patients through India.
How Karetrip Connects International OA Patients to the Right Treatment in India
Osteoarthritis treatment is not a single decision. It is a staged conversation between the patient's disease grade, functional goals, age, and the full range of options available at a specific point in the disease course. Karetrip reviews each international patient's existing imaging and clinical history before recommending a specialist and hospital in India, ensuring the treatment pathway matches the actual disease grade rather than defaulting to either unnecessary surgery or inadequate conservative management.
From pre-travel imaging review and specialist matching, through medical visa support, accommodation coordination near the treating hospital, and discharge planning for physiotherapy continuation at home, Karetrip handles every dimension of the OA treatment journey for international patients.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward understanding the causes of your osteoarthritis and accessing the right treatment in India for where you are in the disease course today.